$CRCW
Crypto Co Stock $crcw

$crcw Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223029509 Filed on August 21, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$124.2K	$106.6K	$151.9K
YoY Change	-50.86%	-29.8%	38.38%
Cost Of Revenue	$14.90K	$117.3K	$82.43K
YoY Change	-84.24%	42.31%
Gross Profit	$109.3K	-$10.71K	$69.44K
YoY Change	-30.91%	-115.42%	-36.73%
Gross Profit Margin	88.0%	-10.04%	45.72%
Selling, General & Admin	$358.0K	$440.4K	$1.405M
YoY Change	-26.52%	-68.66%	93.39%
% of Gross Profit	327.55%		2024.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$32.71K
YoY Change	-100.0%	-100.0%
% of Gross Profit	0.0%		47.11%
Operating Expenses	$368.8K	$451.3K	$1.449M
YoY Change	-30.51%	-68.86%	93.4%
Operating Profit	-$259.5K	-$462.0K	-$1.380M
YoY Change	-30.33%	-66.51%	115.73%
Interest Expense	$99.31K	$346.4K	$600.3K
YoY Change	110.01%	-42.3%	14446.09%
% of Operating Profit
Other Income/Expense, Net	$0.00	$25.78K	$66.77K
YoY Change	-100.0%	-61.39%	-91.6%
Pretax Income	-$358.8K	-$782.6K	-$1.913M
YoY Change	-13.68%	-59.09%	-1366.05%
Income Tax
% Of Pretax Income
Net Earnings	-$358.8K	-$782.6K	-$1.913M
YoY Change	-13.68%	-59.09%	-1366.05%
Net Earnings / Revenue	-288.94%	-734.06%	-1259.7%
Basic Earnings Per Share	$0.00	-$0.08	-$0.08
Diluted Earnings Per Share	$0.00	-$0.08	-$83.18K
COMMON SHARES
Basic Shares Outstanding	96.74M shares	25.62M shares	23.00M shares
Diluted Shares Outstanding	110.8M shares	35.73M shares	23.00M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.44K	$17.68K	$19.21K
YoY Change	-76.25%	-7.96%	-96.46%
Cash & Equivalents	$20.44K	$17.68K	$19.21K
Short-Term Investments
Other Short-Term Assets	$3.750K	$19.12K	$18.83K
YoY Change	-99.65%	1.54%
Inventory
Prepaid Expenses	$3.750K	$19.12K	$18.83K
Receivables
Other Receivables
Total Short-Term Assets	$24.19K	$36.80K	$38.04K
YoY Change	-97.92%	-3.27%	-92.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$740.5K	$740.5K	$740.5K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$989.9K
YoY Change		-100.0%
Total Long-Term Assets	$1.282M	$1.293M	$2.326M
YoY Change	-3.27%	-44.42%	75.3%
TOTAL ASSETS
Total Short-Term Assets	$24.19K	$36.80K	$38.04K
Total Long-Term Assets	$1.282M	$1.293M	$2.326M
Total Assets	$1.306M	$1.330M	$2.364M
YoY Change	-47.5%	-43.75%	26.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.632M	$2.590M	$2.007M
YoY Change	23.47%	29.06%	11.8%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.441M	$2.408M	$2.311M
YoY Change	-5.28%	4.2%	413.56%
Total Short-Term Liabilities	$5.073M	$4.998M	$4.339M
YoY Change	7.73%	15.19%	93.27%
LONG-TERM LIABILITIES
Long-Term Debt	$138.5K	$138.7K	$139.1K
YoY Change	-0.42%	-0.29%	-34.03%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$138.5K	$138.7K	$139.1K
YoY Change	-0.42%	-0.29%	-34.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.073M	$4.998M	$4.339M
Total Long-Term Liabilities	$138.5K	$138.7K	$139.1K
Total Liabilities	$5.211M	$5.136M	$4.478M
YoY Change	7.5%	14.71%	82.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.45M	-$43.10M	-$38.27M
YoY Change	12.3%	12.63%
Common Stock	$39.55M	$39.29M	$36.15M
YoY Change	8.85%	8.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.905M	-$3.807M	-$2.114M
YoY Change
Total Liabilities & Shareholders Equity	$1.306M	$1.330M	$2.364M
YoY Change	-47.5%	-43.75%	26.48%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$358.8K	-$782.6K	-$1.913M
YoY Change	-13.68%	-59.09%	-1366.05%
Depreciation, Depletion And Amortization	$0.00	$0.00	$32.71K
YoY Change	-100.0%	-100.0%
Cash From Operating Activities	-$173.6K	-$303.1K	-$392.7K
YoY Change	-2.53%	-22.82%	-143.83%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	173.4K	304.1K	313.1K
YoY Change	-29.2%	-2.88%	108.73%
NET CHANGE
Cash From Operating Activities	-173.6K	-303.1K	-392.7K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	173.4K	304.1K	313.1K
Net Change In Cash	-180.0	1.010K	-79.59K
YoY Change	-100.27%	-101.27%	-73.77%
FREE CASH FLOW
Cash From Operating Activities	-$173.6K	-$303.1K	-$392.7K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$173.6K	-$303.1K	-$392.7K
YoY Change	-2.53%	-22.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001688126
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee		usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023Q2	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment		usd
	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55726
	dei	Entity Registrant Name EntityRegistrantName	THE CRYPTO COMPANY
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4212105
	dei	Entity Address Address Line1 EntityAddressAddressLine1	23823 Malibu Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	# 50477
	dei	Entity Address City Or Town EntityAddressCityOrTown	Malibu
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90265
	dei	City Area Code CityAreaCode	(424)
	dei	Local Phone Number LocalPhoneNumber	228-9955
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	96738845	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17682	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110606	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	19117	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	81317	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	36799	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	191923	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	552503	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	574169	usd
CY2023Q2	us-gaap	Assets Assets	1329771	usd
CY2022Q4	us-gaap	Assets Assets	1556561	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2589752	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2265548	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2408045	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2211353	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4997797	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4476901	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2023Q2	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	13687	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	14100	usd
CY2023Q2	us-gaap	Liabilities Liabilities	5136484	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4616001	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53821118	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53821118	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23950380	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23950380	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	53821	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	23950	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	39238579	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36448046	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43099113	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39531436	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3806713	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1329771	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1556561	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	106610	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151869	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	255202	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	294381	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117314	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	82433	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	206669	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	176211	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-10705	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	69436	usd
	us-gaap	Gross Profit GrossProfit	48533	usd
	us-gaap	Gross Profit GrossProfit	118170	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	320500	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	506390	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	765525	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1123370	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10833	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10833	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	21666	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	21666	usd
CY2022Q2	us-gaap	Depreciation Depreciation	32708	usd
	us-gaap	Depreciation Depreciation	43611	usd
CY2022Q2	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	109447	usd
	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	6761	usd
	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	272447	usd
CY2023Q2	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	119919	usd
CY2022Q2	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	789602	usd
	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	499718	usd
	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	1512063	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	451253	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1448980	usd
	us-gaap	Operating Expenses OperatingExpenses	1293670	usd
	us-gaap	Operating Expenses OperatingExpenses	2973157	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-461957	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1379545	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1245137	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2854987	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	25775	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	25775	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-31000	usd
CY2022Q2	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment	66765	usd
	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment	81765	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	346402	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	600317	usd
	us-gaap	Interest Expense InterestExpense	2317315	usd
	us-gaap	Interest Expense InterestExpense	1624200	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-782584	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1913096	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3567677	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4397422	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-782584	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1913096	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3567677	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35731866	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35731866	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23000073	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23000073	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30444263	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30444263	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22752500	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22752500	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.00
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000.00	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	386560	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2031499	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	377346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3567677	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3806713	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015815	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015815	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.28
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1740760	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	43750	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1488927	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2113561	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2113561	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3567677	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21666	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	65277	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	506479	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1784510	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2031499	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1488927	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-31000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-62200	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-67350	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	324203	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	72900	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-590629	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-897458	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1033500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1033500	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-18265	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	187062	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	659767	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1866498	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26240	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	497705	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1874473	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-92924	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-56485	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	110606	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75699	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17682	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19214	usd
CY2023Q2	us-gaap	Cash Cash	17682	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3567677	usd
	CRCW	Working Capital WorkingCapital	4960998	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43099113	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z2WPIrz5fQ8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zZ8LsJ5k1vwe">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	54166	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43611	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2023Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1349457	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	740469	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	650000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2281429	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd

Files In Submission

Name	View Source	Status
0001493152-23-029509-index-headers.html	Edgar Link	pending
0001493152-23-029509-index.html	Edgar Link	pending
0001493152-23-029509.txt	Edgar Link	pending
0001493152-23-029509-xbrl.zip	Edgar Link	pending
crcw-20230630.xsd	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex10-4_002.jpg	Edgar Link	pending
ex10-4_003.jpg	Edgar Link	pending
ex10-4_004.jpg	Edgar Link	pending
ex10-4_005.jpg	Edgar Link	pending
ex10-4_006.jpg	Edgar Link	pending
ex10-4_007.jpg	Edgar Link	pending
ex10-4_008.jpg	Edgar Link	pending
ex10-4_009.jpg	Edgar Link	pending
ex10-4_010.jpg	Edgar Link	pending
ex10-4_011.jpg	Edgar Link	pending
ex10-4_012.jpg	Edgar Link	pending
ex10-4_013.jpg	Edgar Link	pending
ex10-4_014.jpg	Edgar Link	pending
ex10-4_015.jpg	Edgar Link	pending
ex10-4_016.jpg	Edgar Link	pending
ex10-4_017.jpg	Edgar Link	pending
ex10-4_018.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-5_001.jpg	Edgar Link	pending
ex10-5_002.jpg	Edgar Link	pending
ex10-5_003.jpg	Edgar Link	pending
ex10-5_004.jpg	Edgar Link	pending
ex10-5_005.jpg	Edgar Link	pending
ex10-5_006.jpg	Edgar Link	pending
ex10-5_007.jpg	Edgar Link	pending
ex10-5_008.jpg	Edgar Link	pending
ex10-5_009.jpg	Edgar Link	pending
crcw-20230630_pre.xml	Edgar Link	unprocessable
crcw-20230630_def.xml	Edgar Link	unprocessable
crcw-20230630_lab.xml	Edgar Link	unprocessable
crcw-20230630_cal.xml	Edgar Link	unprocessable
ex10-5_010.jpg	Edgar Link	pending
ex10-5_011.jpg	Edgar Link	pending
ex10-5_012.jpg	Edgar Link	pending
ex10-5_013.jpg	Edgar Link	pending
ex10-5_014.jpg	Edgar Link	pending
ex10-5_015.jpg	Edgar Link	pending
ex10-5_016.jpg	Edgar Link	pending
ex10-5_017.jpg	Edgar Link	pending
ex10-5_018.jpg	Edgar Link	pending
ex10-5_019.jpg	Edgar Link	pending
ex10-5_020.jpg	Edgar Link	pending
ex10-5_021.jpg	Edgar Link	pending
ex10-5_022.jpg	Edgar Link	pending
ex10-5_023.jpg	Edgar Link	pending
ex10-5_024.jpg	Edgar Link	pending
ex10-5_025.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRCW
Crypto Co Stock $crcw

2023 Q3 Form 10-Q Financial Statement

#000149315223029509 Filed on August 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW Crypto Co Stock $crcw

2023 Q3 Form 10-Q Financial Statement

#000149315223029509 Filed on August 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW
Crypto Co Stock $crcw